MAUDE Adverse Event Report: BIO-RAD MEDICAL DIAGNOSTICS GMBH TANGO OPTIMO; AUTOMATED BLOOD BANK ANALYSER SYSTEM

Model Number	848900010
Health Effect - Clinical Code	No Known Impact Or Consequence To Patient (2692)
Date of Event	08/28/2018
Type of Reportable Event	Malfunction
Additional Manufacturer Narrative
This is our initial report on this incident.
Event or Problem Description
The customer reported a false negative result with anti-b on erytype s abd+rev.A1,b when tested on tango optimo on (b)(6) 2018.Repeat testing of the sample on tango optimo and in the tube yielded a 3+ result.On (b)(6) 2018 the customer performed new tests of other patient samples and got a false negative result in reverse typing with reagent red blood cell a1 of erytypecell a1,b lot 8831011-00.On (b)(6) 2018 the customer observed the third event regarding false reactions in reverse typing.An a pos patient sample yielded a 1+ reaction with reagent red blood cell a1 and a negative with reagent red blood cell b.The customer returned neither the supposedly defective products for investigational testing nor the patient sample that had caused false negative respectively false positive test results.Testing in our quality control laboratory is still ongoing.A review of the batch record documentation showed no irregularities which might have negatively affected the quality of both allegedly defective lots.The affected tango optimo was inspected by our field service engineers.Evaluation of the data is still ongoing.
Additional Manufacturer Narrative
This is our final report on this incident.
Event or Problem Description
The customer reported a false negative result with erytypecell b on erytype when testing on tango optimo on (b)(6) 2018.Repeat testing of the sample on tango optimo and in the tube yielded a 3+ positive result.Due to the initial unclear complaint description of the customer it was not clear whether the false negative reaction occurred on the forward typing with erytype s abd+rev.A1, b or on the reverse typing with erytypecell a1&b.But upon request we were informed that the false negative result occurred with erytypecell b of erytypecell a1&b in the reverse typing on tango optimo.On (b)(6) 2018, the customer performed new tests of other patient samples and got one false negative result in reverse typing with reagent red blood cell a1 of erytypecell a1&b.The result was correctly positive in a repeat testing.On (b)(6) 2018, the customer observed the third event regarding incorrect results in reverse typing.An a positive patient sample yielded a 1+ positive reaction with erytypecell a1 and a negative reaction with erytypecell b.On (b)(6) 2018, the customer observed a false negative result of a patient sample with the blood group o in the reverse typing.In total customer reported false negative results of three different patient samples and a false positive result of one patient sample with erytypecell a1&b on tango optimo.The customer returned neither the supposedly defective product nor the patient samples that had caused false negative respectively false positive test results.Therefore our quality control (qc) laboratory tested their retention sample of erytypecell a1&b with different donor samples on erytype s abd+rev.A1, b on tango optimo.All positive and negative reactions were correct.We did not observe any false negative respectively false positive reaction.Testing by our quality control laboratory confirmed that the allegedly defective lot of erytypecell a1&b functions correctly.A review of the batch record documentation showed no irregularities which might have negatively affected the quality of the allegedly defective lot.The affected tango optimo was inspected by our field service engineers.The received databases and log files were analyzed for any issue relevant anomalies.End of august metrology was performed.The 8 channel turning valve was replaced due to grinding noise.Also a syringe anda valve were replaced.On 09/04/18 the engineer replaced the wash manifold and cleaned the waste tubing.Further, needle, syringe and valve were replaced.Coordinates were checked and adjusted.But the issue re-occurred on 09/13.On 09/16 both pipettor needle adapters were replaced.Upon performance verification procedure the instrument was operating within specifications.Metrology was performed according to the checklist with passing requirements and qc.The instance did not re-occur since last service visit.

• Brand Name: TANGO OPTIMO
• Common Device Name: AUTOMATED BLOOD BANK ANALYSER SYSTEM
• Manufacturer (Section D): BIO-RAD MEDICAL DIAGNOSTICS GMBH; industriestrasse 1; dreieich, hessen 63303 ; GM 63303
• MDR Report Key: 7909173
• Report Number: 9610824-2018-00062
• Device Sequence Number: 1484690
• Product Code: KSZ
• UDI-Device Identifier: 07611969961696
• UDI-Public: (01)07611969961696
• Combination Product (Y/N): N
• Initial Reporter State: NY
• Initial Reporter Country: US
• PMA/510(K) Number: BK080013
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Reporter Type: Manufacturer
• Report Source: health professional,user faci
• Initial Reporter Occupation: Other
• Type of Report: Initial,Followup
• Report Date (Section B): 10/24/2018

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Model Number: 848900010
• Device Catalogue Number: 848 900 010
• Was Device Available for Evaluation?: Yes
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 08/29/2018
• Supplement Date Received by Manufacturer: 08/29/2018
• Initial Report FDA Received Date: 09/26/2018
• Supplement Report FDA Received Date: 10/24/2018
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Patient Sequence Number: 1
• Concomitant Medical Products and Therapy/Usage Dates: ERYTYPE S ABD+REV. A1,B, LOT 8809190; ERYTYPE S ABD+REV. A1,B, LOT 8809190; ERYTYPECELL A,B, LOT 8831011-00; ERYTYPECELL A,B, LOT 8831011-00